A critical advance in cancer research is emerging with the use of VHH fragments to reactivate dysfunctional p53. This essential malignant protector protein is frequently disabled in several types of malignancies, https://socialbookmarkgs.com/story21967648/nanobodies-restore-tumor-suppressor-p53-new-potential-approach-for-malignant-therapy